Evolus, Inc. (EOLS) |
| 7.51 -0.24 (-3.1%) 10-13 16:00 |
| Open: | 7.68 |
| High: | 7.7 |
| Low: | 7.475 |
| Volume: | 654,407 |
| Market Cap: | 495(M) |
| PE Ratio: | -23.78 |
| Exchange: | NASDAQ Global Market |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 9.05 |
| Resistance 1: | 8.23 |
| Pivot price: | 7.73 |
| Support 1: | 6.91 |
| Support 2: | 5.75 |
| 52w High: | 9.31 |
| 52w Low: | 3.86 |
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Financials
| EPS | -0.530 |
| Book Value | -0.470 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.182 |
| Profit Margin (%) | -10.85 |
| Operating Margin (%) | -5.17 |
| Return on Assets (ttm) | -5.7 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 12 Oct 2026
EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS Law - Business Wire
Thu, 08 Oct 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS - PR Newswire
Fri, 02 Oct 2026
Evolus Stock Price Forecast. Should You Buy EOLS? - StockInvest.us
Fri, 02 Oct 2026
Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drug - Evolus (NASDAQ:EOLS) - Benzinga
Fri, 02 Oct 2026
Evolus gets FDA warnings over Jeuveau IG post (EOLS:NASDAQ) - Seeking Alpha
Thu, 01 Oct 2026
At participating practices, each patient check-in will send $1 to cancer support. - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
